Bacteria, beware: New finding about E coli could block infections, lead to better treatmentsJune 27, 2006A newly discovered receptor in a strain of Escherichia coli can be blocked to avert infection, a finding that might aid in developing better therapies to treat bacterial infections resulting in food poisoning, diarrhea or plague. Researchers at UT Southwestern Medical Center are the first to identify the receptor, known as QseC, used by a diarrhea-causing strain of E coli to receive signals from human flora and hormones in the intestine and express virulence genes to initiate infection. In a study made available online this week and in an upcoming issue of the Proceedings of the National Academy of Sciences, researchers describe how they used phentolamine, an alpha blocker drug used to treat hypertension, to successfully impede signaling to the receptor. Without such signals, bacteria then pass blindly through the digestive tract without infecting cells.
"This receptor is found in many pathogens, so we can use this knowledge to design specific antagonists to block bacterial infections," said Dr. Vanessa Sperandio, senior author of the study and assistant professor of microbiology at UT Southwestern. Prior research by Dr. Sperandio found that when a person ingests the more virulent enterohemorrhagic E coli, or EHEC — which is usually transmitted through contaminated food such as raw meat — it travels peacefully through the digestive tract until reaching the intestine. There, however, chemicals produced by the friendly gastrointestinal microbial flora and the human hormones epinephrine and norepinephrine alert the bacteria to its location. This cellular cross talk triggers a cascade of genetic activations prompting EHEC to colonize and translocate toxins into cells, altering the makeup of the cells and robbing the body of nutrients. An infected person may develop bloody diarrhea or even hemolytic uremic syndrome, which can cause death in immune-weakened people, the elderly and young children. The new study identifies QseC as the specific receptor by which EHEC senses the signals. When the receptor binds to signaling molecules, the bacterium can infect cells. Researchers tested the capacity of adrenergic antagonists, drugs such as alpha and beta blockers, to disrupt the receptor's sensing ability. They found that phentolamine binds to the QseC receptor and occupies the pocket that the receptor would use to recognize the host epinephrine and norepinephrine signals — thus blocking the QseC receptor from sensing the signals and preventing it from being able to express its virulence genes in cells. This knowledge opens the door to further understanding of the signaling processes between microbes and humans and to the development of novel treatments of bacterial infections with antagonists to these signals, Dr. Sperandio said. New therapies are important because treating some bacterial infections with conventional antibiotics can cause the release of more toxins and may worsen disease outcome. That importance is magnified because of the QseC receptor's existence in other types of bacteria, including, Shigella, which causes dysentery; Salmonella, which causes food poisoning and gastroenteritis; and Yersinia, which causes bubonic plague. Those are all emerging infectious diseases that afflict thousands of people each year in the United States and worldwide, according to the Centers for Disease Control and Prevention. "Overuse of antibiotics has led bacteria to develop resistance to antibiotics, so a novel type of therapy is needed," Dr. Sperandio said. UT Southwestern Medical Center | |||||||||||||||||||||
|
Related Infection Current Events and Infection News Articles U of T researchers reveal Epstein-Barr virus protein contributes to cancer Researchers at the University of Toronto have discovered that the EBNA1 protein of Epstein-Barr virus (EBV) disrupts structures in the nucleus of nasopharyngeal carcinoma (NPC) cells, thereby interfering with cellular processes that normally prevent cancer development. Oral vitamin D may help prevent some skin infections A study led by researchers at the University of California, San Diego School of Medicine suggests that use of oral Vitamin D supplements bolsters production of a protective chemical normally found in the skin, and may help prevent skin infections that are a common result of atopic dermatitis, the most common form of eczema. Study: Bird diversity lessens human exposure to West Nile Virus A study by biologists at Washington University in St. Louis shows that the more diverse a bird population is in an area, the less chance humans have of exposure to West Nile Virus (WNV). Hopkins children's experts say doctors and parents can sort out symptoms with a checklist A young child arrives at the emergency room after several days of abdominal pain, vomiting, and diarrhea and is sent home with a diagnosis of viral gastritis and treatment for the symptoms. 'Deadly dozen' reports diseases worsened by climate change Health experts from the Wildlife Conservation Society today released a report that lists 12 pathogens that could spread into new regions as a result of climate change, with potential impacts to both human and wildlife health and global economies. Form of Crohn's disease traced to disabled gut cells Scientists report online this week in Nature that they have linked the health of specialized gut immune cells to a gene associated with Crohn's disease, an often debilitating and increasingly prevalent inflammatory bowel disorder. New test could help catch serious infections in babies A simple blood test may help detect serious bacterial infections (SBIs) like urinary tract infections and blood stream infections in young infants who come to the emergency department (ED) with fevers that have no clear cause. DNA of good bacteria drives intestinal response to infection A new study shows that the DNA of so-called "good bacteria" that normally live in the intestines may help defend the body against infection. New Catheter-less Technique May Ease the Pain and Discomfort of Prostate Cancer Recovery To ease the pain of recovery following prostate cancer surgery, physician-scientists have developed an innovative and patient-friendly approach that eliminates the use of a penile urinary catheter. MU scientists 'see' how HIV matures into an infection After improving the sensitivity of nuclear magnetic resonance (NMR), researchers at the University of Missouri actually watched the HIV-1 protease mature from an inactive form into an active infection. This process has never been directly visualized before. The findings appear today in the journal Nature. More Infection Current Events and Infection News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||